Investment
Features
FeesSafety
Academy
More
Pluang+

Compare HubSpot Inc (HUBS) vs Revolution Medicines Inc. Common Stock (RVMD) Price & Performance

HubSpot IncTrade
Revolution Medicines Inc. Common StockTrade

Price performance (Past 24H)

Key statistics

HubSpot Inc vs Revolution Medicines Inc. Common Stock — how do they compare? HubSpot Inc trades at $229.02 (market cap $11.56B), while Revolution Medicines Inc. Common Stock trades at $192.62 (market cap $40.32B). The key difference: Revolution Medicines Inc. Common Stock is far larger — about 3.5× HubSpot Inc's market cap, and Revolution Medicines Inc. Common Stock is trading nearer its 52-week high, HubSpot Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold HubSpot Inc for 78 Days and Revolution Medicines Inc. Common Stock for 0 Days on average.

HUBSRVMD
Market Cap
$11.56B$40.32B
Volume
1,891,2874,855,734
Sector
TechnologyHealth
52-Week High
$494.58$221.15
52-Week Low
$170.39$47.50
Typical Hold Time
78 Days0 Days
Enterprise Value
$10.46B$37.02B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

HubSpot Inc

HubSpot (HUBS) trades at $233.94, up 6.19% today, with a bearish technical signal but strong recent earnings beats. The company reported Q2 2026 EPS of $3.26, beating estimates of $3.02, continuing a trend of positive surprises. Revenue growth is robust, with 2025 revenue at $3.13 billion, and net income turning positive at $45.91 million. Analyst sentiment remains largely positive with a consensus price target of $243.65, though valuation multiples like a P/E of 82.51 are elevated. Recent news highlights AI strategy advancements and partnerships, including a deepened collaboration with OpenAI.

The outlook for HUBS is cautiously optimistic, driven by strong revenue growth, margin expansion potential, and strategic AI initiatives. Key risks include high valuation multiples, competitive pressures in the CRM space, and potential demand headwinds from economic conditions. Institutional ownership trends show significant interest, such as the California State Teachers Retirement System increasing its stake. The stock presents a growth opportunity but requires monitoring of execution risks and market sentiment shifts.

Revolution Medicines Inc. Common Stock

No Aura AI signal available yet.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

HUBS
0% Buy100% Sell
Avg holding period · 78 Days
RVMD
100% Buy0% Sell
Avg holding period · 0 Days

Top news

Latest headlines on both assets

About HubSpot Inc

HubSpot provides a cloud-based marketing, sales, and customer service software platform referred to as the growth platform. The applications are available ala carte or packaged together. HubSpot's mission is to help companies grow better and has expanded from its initial focus on inbound marketing to embrace marketing, sales, and service more broadly. The company was founded in 2006, completed its initial public offering in 2014, and is headquartered in Cambridge, Massachusetts.

Read more on HUBS →

About Revolution Medicines Inc. Common Stock

Revolution Medicines develops precision medicines for cancer. Its programs focus on targeting RAS-driven cancers and related signaling pathways.

Read more on RVMD →